Literature DB >> 15830469

Properties of R plasmids determining gentamicin resistance by acetylation in Pseudomonas aeruginosa.

G A Jacoby.   

Abstract

Two clinical isolates of Pseudomonas aeruginosa, one a pyocin type 5 strain from Atlanta, could transfer gentamicin resistance by conjugation. Donor and recipient strains inactivated gentamicin by acetylation. The R plasmids, pMG1 and pMG2, also determined resistance to sisomicin, another substrate of gentamicin acetyltransferase I, sulfonamides, and streptomycin, but not resistance to kanamycin, neomycin, tobramycin, butirosin, or BB-K 8. They were transmissible to many strains of P. aeruginosa, including a Rec(-) strain, but not to Escherichia coli or other enterobacteriaceae. These R plasmids were compatible with R plasmids transmissible to P. aeruginosa from E. coli, including members of C, N, P, and W incompatibility groups. From a strain carrying pMG1 and a compatible plasmid, pMG1 was transferred independently but transfer of the second plasmid often resulted in cotransfer of pMG1. In contrast, pMG1 and pMG2 were incompatible with pseudomonas R plasmids R931 and R3108, and with R931 they readily formed recombinant plasmids. The four plasmids in this incompatibility group determine additional biological properties, including resistance to inorganic and organic mercury compounds, to ultraviolet light, and to certain deoxyribonucleic acid phages. pMG1 and pMG2 also phenotypically inhibited pyocin production. Consequently such R plasmids alter the phage and pyocin types of their host strains.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 15830469      PMCID: PMC444633          DOI: 10.1128/AAC.6.3.239

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  49 in total

Review 1.  Pseudomonas genetics.

Authors:  B W Holloway; V Krishnapillai; V Stanisich
Journal:  Annu Rev Genet       Date:  1971       Impact factor: 16.830

2.  Selective enrichment of R- segregants as the main mechanism of "curing" of the R factor by acridine dyes.

Authors:  M Yoshikawa
Journal:  Genet Res       Date:  1971-02       Impact factor: 1.588

3.  Enzymatic acetylation of aminoglycoside antibiotics by Escherichia coli carrying an R factor.

Authors:  R Benveniste; J Davies
Journal:  Biochemistry       Date:  1971-05-11       Impact factor: 3.162

4.  Microbiologic studies related to bacterial resistance to gentamicin.

Authors:  M J Weinstein; C G Drube; E L Moss; J A Waitz
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

5.  The evolution and spread of gentamicin-resistant Pseudomonads.

Authors:  H H Stone; L D Kolb
Journal:  J Trauma       Date:  1971-07

6.  Enzymatic inactivation of gentamicin C components by cell-free extract from Pseudomonas aeruginosa.

Authors:  S Mitsuhashi; F Kobayashi; M Yamaguchi
Journal:  J Antibiot (Tokyo)       Date:  1971-06       Impact factor: 2.649

7.  Investigation of the mating system of Pseudomonas aeruginosa strain I. VI. Mercury resistance associated with the sex factor (FP).

Authors:  J S Loutit
Journal:  Genet Res       Date:  1970-10-02       Impact factor: 1.588

8.  Infection of Pseudomonas aeruginosa spheroplasts by RNA from a pilus phage.

Authors:  R M Weppelman; C C Brinton
Journal:  Virology       Date:  1970-05       Impact factor: 3.616

9.  Biochemical studies on gentamicin resistance.

Authors:  N Tanaka
Journal:  J Antibiot (Tokyo)       Date:  1970-09       Impact factor: 2.649

10.  Epidemiological fingerprinting of Pseudomonas aeruginosa by the production of and sensitivity of pyocin and bacteriophage.

Authors:  J J Farmer; L G Herman
Journal:  Appl Microbiol       Date:  1969-11
View more
  72 in total

1.  Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece.

Authors:  A Tsakris; S Pournaras; N Woodford; M F Palepou; G S Babini; J Douboyas; D M Livermore
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

2.  Activity of beta-lactam antibiotics against Pseudomonas aeruginosa carrying R plasmids determining different beta-lactamases.

Authors:  G A Jacoby; L Sutton
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

3.  Transduction of Pseudomonas aeruginosa with a mutant of bacteriophage E79.

Authors:  A F Morgan
Journal:  J Bacteriol       Date:  1979-07       Impact factor: 3.490

4.  Bactericidal activity of the tail of Pseudomonas aeruginosa bacteriophage PS17.

Authors:  T Shinomiya; S Shiga
Journal:  J Virol       Date:  1979-12       Impact factor: 5.103

Review 5.  Chromosomal genetics of Pseudomonas.

Authors:  B W Holloway; V Krishnapillai; A F Morgan
Journal:  Microbiol Rev       Date:  1979-03

6.  OXA-17, a further extended-spectrum variant of OXA-10 beta-lactamase, isolated from Pseudomonas aeruginosa.

Authors:  F Danel; L M Hall; B Duke; D Gur; D M Livermore
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

7.  IMP-29, a novel IMP-type metallo-β-lactamase in Pseudomonas aeruginosa.

Authors:  Katy Jeannot; Laurent Poirel; Marjorie Robert-Nicoud; Pascal Cholley; Patrice Nordmann; Patrick Plésiat
Journal:  Antimicrob Agents Chemother       Date:  2012-01-30       Impact factor: 5.191

8.  bla(IMP-9) and its association with large plasmids carried by Pseudomonas aeruginosa isolates from the People's Republic of China.

Authors:  Jianhui Xiong; Michael F Hynes; Huifen Ye; Huiling Chen; Yinmei Yang; Fatima M'zali; Peter M Hawkey
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

9.  Isolation and characterization of mutant Pseudomonas aeruginosa strains unable to assimilate nitrate.

Authors:  R M Jeter; J L Ingraham
Journal:  Arch Microbiol       Date:  1984-06       Impact factor: 2.552

10.  Multiresistant plasmids from Pseudomonas aeruginosa highly resistant to either or both gentamicin and carbenicillin.

Authors:  P Kontomichalou; E Papachristou; F Angelatou
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.